Management tracks: Sirtex makes interim CEO permanent; plus Magenta, Pyxis, Stoke, Cadent, StemoniX, Enzyvant, Syapse and Stalicla

Sirtex Medical Ltd. (ASX:SRX) named Kevin Smith CEO. He was interim CEO and, before that, the cancer therapy company's EVP, sales & marketing for the Americas. Prior

Read the full 276 word article

User Sign In